Navigation Links
Iowa Staters talk biofuels, healthy oils and 'pharma crops' at AAAS meeting
Date:2/16/2008

AMES, Iowa Theres more to biofuels than the food vs. fuel debate and talk of the various technologies associated with biofuels production.

And so Steven Fales, a professor of agronomy and a member of the Science and Engineering Board of Iowa States Bioeconomy Institute, organized and moderated a three-hour symposium on Friday, Feb. 15, at the annual meeting of the American Association for the Advancement of Science in Boston.

The title of the discussion was, Energy, Agriculture, and People: Global Implications for Science and Policy.

We thought it would be appropriate to take a big picture view of issues regarding energy and agriculture that go beyond the science and technology, Fales said.

And so there were presentations about climate change, production of biofuel crops on marginal lands, the effects of biofuel production on the poor, the ethics of using agriculture for energy production and the politics associated with renewable energy.

Fales said the idea was to mirror the global theme of the annual meeting and acknowledge that biorenewable issues extend beyond energy into many other concerns of society.

Two other researchers with ties to Iowa State also made presentations during the AAAS annual meeting Feb. 14-18:

Robert Wisner, a recently retired University Professor of agricultural economics, addressed a 90-minute symposium on Friday, Feb. 15, titled, Drugs in our Corn Flakes" Our Health and the Economic Risks of Pharma and Industrial Crops.

Wisners talk addressed the economics of growing crops with medicinal traits engineered into them. Key economic issues include the risks of co-mingling medical drugs and industrial chemicals with the food supply and the alternatives for controlling that risk. But those arent the only economic issues he identified. Others were determining the real and long-term costs and benefits of pharma crops, identifying who gains from the crops and learning whether producing medicines and chemicals in non-food crops is more economical and less risky than using food crops. Wisner also noted several instances when unapproved genetically modified crops were found in food supplies. In those instances, Wisner said there were major disruptions in grain export markets, price impacts and very high public and private costs to purge the grain from the food system.

Linda Pollak, a research geneticist for the U.S. Department of Agriculture and a collaborative associate professor of agronomy at Iowa State, addressed a 90-minute symposium on Saturday, Feb. 16, titled, Crops for Health: Improving the Health-Promoting Properties of Food.

Pollaks message was that traditional plant breeding can be a tool to improve human health. Plant breeders, for example, have been able to reduce some of the problems with oils from soybeans, canola, sunflowers and corn. She said plant breeders have developed soybeans with lower levels of fatty acids to help reduce trans fats after processing. Breeders have also developed canola lines with safe levels of toxic erucic acid. And plant breeders have decreased saturated fats and increased monounsaturated fats in canola, sunflower and corn oils to reduce the risk of heart disease. And so Pollak argued traditional plant breeding can still develop better crops for healthier foods.


'/>"/>

Contact: Mike Krapfl
mkrapfl@iastate.edu
515-294-4917
Iowa State University
Source:Eurekalert

Related biology news :

1. Youre likely to order more calories at a healthy restaurant
2. Studies: Children obese due to a host of unhealthy pressures
3. New study shows Concord grape juice has a heart-healthy effect not yet reported with red wine
4. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
5. Insect gut detects unhealthy meal
6. Want healthy gums? Hit the dairy aisle
7. Bacteria from sponges make new pharmaceuticals
8. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
9. Biopharmaceutical infrastructure key to lower drug development costs
10. NMR researchers unlock hydrogens secrets to spot polymorphism in pharmaceuticals
11. Biotech Co. founded by UCLA Scientists to be acquired by Astellas, Pharma Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
Breaking Biology Technology: